Researchers characterize three ways in which the gene FOXA1 mutates to trigger prostate cancer.

The largest study of its kind finds societal factors and access to quality care, rather than genetics, underlies higher prostate cancer mortality rates for black men.

A new study finds that U-M-designed compounds led to significantly smaller, slower-growing tumors.

A new U-M study assesses the short-term degrees of discomfort associated with prostate MRIs and biopsies, offering insights for future prostate cancer patient care.

Tumors with alterations in the CDK12 gene were more responsive to immunotherapy, suggesting a precision medicine approach.

Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy.